Skip to main content
Equibles

TORONTO DOMINION BANK

Bank

Position in REPL — Replimune Group, Inc.

CIK 947263 TORONTO, ONTARIO, A6
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,114,250
+$1,942,871 QoQ
Shares Held
1,275,000
-19.9% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#19
of 199 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TORONTO DOMINION BANK holds $769,395,513 across 60 Biotechnology names. REPL ranks #10 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PTCT
Ptc Therapeutics, Inc.
 2,165,846 $176,668,057
2 CELC
Celcuity Inc.
 1,258,758 $131,691,261
3 STOK
Stoke Therapeutics, Inc.
 3,173,258 $103,829,001
4 MDGL
Madrigal Pharmaceuticals, Inc.
 181,432 $97,419,912
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 85,391 $42,416,270
6 TARS
Tarsus Pharmaceuticals, Inc.
 510,253 $32,115,323
7 REGN
Regeneron Pharmaceuticals, Inc.
 48,783 $30,418,151
8 NGNE
Neurogene Inc.
 681,337 $21,428,048

All Filings in REPL

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,114,250 1,275,000
2026-03-31 $12,171,379 1,591,030
2025-12-31 $21,671,002 2,229,527
2025-09-30 $5,748,897 1,372,052